Source: Annual Congress 2007 - Environmental and clinical aspects of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Ekberg-Aronsson, G. Engstrom, F. Lindgarde (Lund, Malmö, Sweden). A prospective study of systemic inflammation and FEV₁ decline. Eur Respir J 2007; 30: Suppl. 51, 1920

Member's Comments

No comment yet.

Related content which might interest you: HsCRP is associated with COPD and a faster decline in FEV1 - a multicentre epidemiological study Source: Eur Respir J 2005; 26: Suppl. 49, 51s Year: 2005 1-year prospective study in severe COPD patients: marker of inflammation, lung function and radiologic evaluation Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007 Sex-specific effect of body weight gain on systemic inflammation in subjects with COPD: results from the SAPALDIA cohort study 2 Source: Eur Respir J 2009; 33: 332-339 Year: 2009 Short-term HRQL deterioration during early-phase COPD exacerbation: a prospective Canadian cohort study Source: Eur Respir J 2005; 26: Suppl. 49, 296s Year: 2005 Eosinophilic inflammation and lung function decline in a long-term follow-up of a large population-based asthma cohort Source: International Congress 2018 – Asthma in children and adults: long-term aspects Year: 2018 Predictors of accelerated decline in FEV1 in a prospective new-onset asthma cohort Source: International Congress 2016 – Phenotyping asthma Year: 2016 D-dimer as a predictor of persistent pulmonary function impairment after COVID-19 pneumonia: a prospective observational study Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases Year: 2021 The influence of lung volume reduction surgery on exercise in patients with COPD Source: Eur Respir J 2004; 23: 269-274 Year: 2004 The longitudinal relationship between bacterial load airway inflammation and lung function decline in patients with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 212s Year: 2002 Inhaled corticosteroids and FEV1 decline in asthma: an international cohort study Source: International Congress 2018 – Asthma in children and adults: long-term aspects Year: 2018 Predictors of lung function decline: a retrospective study in COPD patients Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 EXACT-PRO correlates with FEV1 and systemic inflammation but not airway inflammation Source: International Congress 2019 – Clinical implications of COPD management Year: 2019 A single-center observational study assessing response to mepolizumab in severe eosinophilic asthma Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019 Iron deficiency and lung function decline in stable COPD – a prospective cohort study Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 Relationships between lung physiology and airway and systemic inflammation: a cohort study in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 144s Year: 2006 Welding, longitudinal lung function decline and chronic respiratory symptoms: a systematic review of cohort studies Source: Eur Respir J 2013; 42: 1186-1193 Year: 2013 The role of concomitant respiratory diseases on the rate of decline in FEV1 among adult asthmatics Source: Eur Respir J 2003; 21: 95-10 Year: 2003 Reducing the decline of FEV1 after a 4-year therapy with montelukast in patients with bronchial asthma Source: Annual Congress 2008 - Recent advances in the pathogenesis and treatment of asthma and COPD Year: 2008 Oral or inhaled corticosteroids for patients with chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=281 Year: 2006 The evaluation of different factors that cause FEV1 decline in patients with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 135s Year: 2001